• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用¹²⁵I对葡萄糖-Tyr3-奥曲肽进行放射性标记及其在大鼠体内的代谢分析:与放射性标记的DOTA-Tyr3-奥曲肽比较

Radiolabelling of glucose-Tyr3-octreotate with 125I and analysis of its metabolism in rats: comparison with radiolabelled DOTA-Tyr3-octreotate.

作者信息

Petrik Milos, Laznickova Alice, Laznicek Milan, Zalutsky Michael R

机构信息

Department of Biophysics and Physical Chemistry, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.

出版信息

Anticancer Res. 2007 Nov-Dec;27(6B):3941-6.

PMID:18225554
Abstract

BACKGROUND

Somatostatin analogues labelled with radiometals or radiohalogens are useful for the imaging and treatment of somatostatin receptor-containing tumours. In this study, the procedures for the radioiodination of glucose-Tyr3-octreotate (gluc-Tyr3-tate) and radiolabelling of DOTA-Tyr3-octreotate (DOTA-Tyr3-tate) with 111In, 177Lu and 125I were compared and their metabolism in rats was analyzed. The usefulness of high performance liquid chromatography (HPLC) analysis and instant thin-layer chromatography on silica gel (ITLC-SG) for both radiochemical purity determination and analysis of metabolism in urine was investigated.

MATERIALS AND METHODS

For labelling with radiometals, the formation of a complex with the 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) functionality of the peptide was employed. Radioiodination was performed by the chloramime-T method. The radiochemical purity of radiolabelled peptides and the analyses of rat urine were determined by HPLC and/or ITLC-SG methods. Male Wistar rats were used in the elimination studies.

RESULTS

DOTA-Tyr3-tate was simply radiolabelled with radiometals with high yield and high radiochemical purity. Stopping of the reaction was a critical step for radioiodination, therefore labelling of gluc-Tyr3-tate and DOTA-Tyr3-tate with 125I was not so simple and the reaction product had to be purified by preparative HPLC analysis. Whereas 111In-DOTA-Tyr3-tate and 177Lu-DOTA-Tyr3-tate were eliminated in rat urine in a practically unchanged form, a significant proportion of metabolites was observed with radioiodinated peptides, particularly at longer time intervals.

CONCLUSION

Labelling of DOTA-Tyr3-tate with radiometals is simple and the radiochemical purity of prepared compounds is very high, while iodination of the peptides demands purification of the product by preparative HPLC. The analysis of rat urine showed that excretion of radioiodinated peptides included a significant proportion of metabolites.

摘要

背景

用放射性金属或放射性卤素标记的生长抑素类似物可用于含生长抑素受体肿瘤的成像和治疗。在本研究中,比较了葡萄糖 - 酪氨酰 -3-奥曲肽(gluc - Tyr3 - tate)的放射性碘化和用111铟、177镥和125碘对DOTA - 酪氨酰 -3-奥曲肽(DOTA - Tyr3 - tate)进行放射性标记的过程,并分析了它们在大鼠体内的代谢情况。研究了高效液相色谱(HPLC)分析和硅胶快速薄层层析(ITLC - SG)在放射性化学纯度测定和尿液代谢分析中的实用性。

材料与方法

对于用放射性金属进行标记,采用与肽的1,4,7,10 - 四氮杂环十二烷 -1,4,7,10 - 四乙酸(DOTA)官能团形成络合物的方法。通过氯胺 - T法进行放射性碘化。用HPLC和/或ITLC - SG方法测定放射性标记肽的放射性化学纯度和大鼠尿液分析。在消除研究中使用雄性Wistar大鼠。

结果

DOTA - Tyr3 - tate用放射性金属简单地进行放射性标记,产率高且放射性化学纯度高。反应终止是放射性碘化的关键步骤,因此用125碘标记gluc - Tyr3 - tate和DOTA - Tyr3 - tate并不那么简单,反应产物必须通过制备型HPLC分析进行纯化。虽然111铟 - DOTA - Tyr3 - tate和177镥 - DOTA - Tyr3 - tate以几乎不变的形式从大鼠尿液中排出,但在用放射性碘标记的肽中观察到相当比例的代谢物,特别是在较长时间间隔时。

结论

用放射性金属标记DOTA - Tyr3 - tate很简单,制备的化合物放射性化学纯度非常高,而肽的碘化需要通过制备型HPLC对产物进行纯化。大鼠尿液分析表明,放射性碘标记肽的排泄包括相当比例的代谢物。

相似文献

1
Radiolabelling of glucose-Tyr3-octreotate with 125I and analysis of its metabolism in rats: comparison with radiolabelled DOTA-Tyr3-octreotate.用¹²⁵I对葡萄糖-Tyr3-奥曲肽进行放射性标记及其在大鼠体内的代谢分析:与放射性标记的DOTA-Tyr3-奥曲肽比较
Anticancer Res. 2007 Nov-Dec;27(6B):3941-6.
2
Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities.在高比活度下用90Y、111In和177Lu对DOTA肽进行放射性标记的条件优化。
Eur J Nucl Med Mol Imaging. 2003 Jun;30(6):917-20. doi: 10.1007/s00259-003-1142-0. Epub 2003 Apr 4.
3
Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a "Cu(I)-click" and "sulfo-click" ligation method.通过“Cu(I)-点击”和“磺基点击”连接方法合成的 DOTA 缀合二聚体[Tyr3]奥曲肽肽的体内性质的间隔物效应。
Chembiochem. 2011 Mar 21;12(5):750-60. doi: 10.1002/cbic.201000639. Epub 2011 Feb 15.
4
DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy.DOTA-D-酪氨酸(1)-奥曲肽:一种用于用金属和卤素放射性核素标记的生长抑素类似物,用于癌症成像和治疗。
Bioconjug Chem. 2002 Jul-Aug;13(4):721-8. doi: 10.1021/bc015590k.
5
The development and validation of a high performance liquid chromatography method to determine the radiochemical purity of [Lu]Lu-HA-DOTA-TATE in pharmaceutical preparations.建立并验证高效液相色谱法测定药物制剂中 [Lu]Lu-HA-DOTA-TATE 的放射化学纯度。
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 May 1;1171:122605. doi: 10.1016/j.jchromb.2021.122605. Epub 2021 Feb 27.
6
Comparison of 111In-DOTA-NOC and 111I-DOTA-TATE distribution in the target and dose-limiting tissues: conflicting results in vitro and in vivo.111铟-多胺大环配体-奥曲肽与111碘-多胺大环配体-生长抑素类似物在靶组织和剂量限制组织中的分布比较:体外和体内的矛盾结果
Anticancer Res. 2008 Jul-Aug;28(4B):2189-95.
7
Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy.[DTPA0]奥曲肽、[DTPA0,Tyr3]奥曲肽和[DOTA0,Tyr3]奥曲肽作为生长抑素受体靶向闪烁扫描和放射性核素治疗载体的临床前比较。
Int J Cancer. 1998 Jan 30;75(3):406-11. doi: 10.1002/(sici)1097-0215(19980130)75:3<406::aid-ijc14>3.0.co;2-6.
8
Fundamental study of radiogallium-labeled aspartic acid peptides introducing octreotate derivatives.引入奥曲肽衍生物的放射性镓标记天冬氨酸肽的基础研究。
Ann Nucl Med. 2019 Apr;33(4):244-251. doi: 10.1007/s12149-018-01326-5. Epub 2019 Jan 3.
9
Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides.基于SnO2的68Ge/68Ga发生器的特性以及DOTA肽放射性标记的相关方面。
Appl Radiat Isot. 2011 Feb;69(2):308-15. doi: 10.1016/j.apradiso.2010.11.015. Epub 2010 Nov 23.
10
Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro.用177Lu或90Y放射性标记的Tyr3-奥曲肽和Tyr3-奥曲瑞肽:肽受体放射性核素治疗的体外结果
Cancer Biother Radiopharm. 2003 Oct;18(5):761-8. doi: 10.1089/108497803770418300.

引用本文的文献

1
Somatostatin receptors as a new active targeting sites for nanoparticles.生长抑素受体作为纳米颗粒的新型主动靶向位点。
Saudi Pharm J. 2018 Nov;26(7):1051-1059. doi: 10.1016/j.jsps.2018.05.014. Epub 2018 May 31.
2
[Lu]-DOTA-Tyr-octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma.[Lu]-DOTA-酪胺-奥曲肽:一种用于治疗髓母细胞瘤的潜在靶向放射治疗药物。
Curr Radiopharm. 2010;3(1):29-36. doi: 10.2174/1874471011003010029.